Associations of hypoglycemic medications, cordycepin and vaccination with clinical outcomes in diabetic kidney disease patients with COVID-19
Yanan Liu, Xuejie Yao, Jianhang Xu, Richard Hubbard, Allen G Ross, Muhammad J A Shiddiky, Ming Zhan
Renal Failure, doi:10.1080/0886022x.2025.2584572
the associations between hypoglycemic medications, cordycepin, COVid-19 vaccination, and clinical outcomes of SaRS-CoV-2 infection were examined in a retrospective cohort of patients with diabetic kidney disease (dKd) in ningbo, China, between december 2022 and June 2023. acute COVid-19 outcomes included fever, pneumonia, hospitalization, and prolonged symptoms. Short-term dKd outcomes at three months post-infection included a serum creatinine increase ≥ 30%, an estimated glomerular filtration rate (eGFR) decrease ≥ 10 ml/min/1.73 m 2 , a urinary albumin-to-creatinine ratio (uaCR) increase ≥ 30%, a fasting blood glucose increase ≥ 1.1 mmol/l, and a hemoglobin a1c (Hba1c) increase ≥ 0.3%. among 642 dKd patients with COVid-19, 66.8% were treated with sodium-glucose cotransporter-2 inhibitors (SGlt2i) at baseline, 36.9% with dipeptidyl peptidase-4 inhibitors (dPP4i), 30.8% with metformin, and 36.4% with cordycepin. logistic regression analysis indicated that SGlt2i use was associated with a reduced risk of hospitalization and less worsening of uaCR. Metformin use was linked to a lower incidence of COVid-19 pneumonia but an increased risk of serum creatinine elevation. dPP4i use showed no significant association with adverse outcomes. Cordycepin use was associated with reduced risks of hospitalization and serum creatinine elevation. Compared with unvaccinated patients, multiple-dose COVid-19 vaccination was associated with reduced risks of adverse outcomes, including prolonged COVid-19 symptoms, pneumonia, decreased eGFR, and elevated blood glucose and Hba1c levels. in conclusion, pretreatment with SGlt2i, cordycepin, and multiple-dose COVid-19 vaccination was associated with reduced adverse outcomes among dKd patients with COVid-19.
Ethical approval the study was approved by the Ethics Committee of the First affiliated Hospital of ningbo university (Ethics approval no: 2024132RS01), and was conducted in accordance with the declaration of Helsinki treaty.
Authors' contributions M.Z. and y.l. designed and conducted the study, analyzed the data, and drafted the manuscript. X.y. and J.X. were involved in conducting the investigations, collecting and analyzing the data. R.H. provided statistical support, reviewed and edited the manuscript; a.R. and M.S. contributed to the discussion and reviewed and edited the manuscript.
Disclosure statement the authors declare no conflict of interest associated with the paper.
References
Al-Kuraishy, Ai, COVid-19 and risk of acute ischemic stroke and acute lung injury in patients with type ii diabetes mellitus: the anti-inflammatory role of metformin, Front Med,
doi:10.3389/fmed.2021.644295Altoukhi, Zamkah, Alharbi Ra, understanding the effects of COVid-19 on patients with diabetic nephropathy: a systematic review, ann Med Surg (lond),
doi:10.1097/MS9.0000000000002053Barron, Bakhai, Kar, associations of type 1 and type 2 diabetes with COVid-19-related mortality in England: a whole-population study, lancet diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30272-2Bermingham, Pouwels, trajectory of long covid symptoms after covid-19 vaccination: community based cohort study, BMJ,
doi:10.1136/bmj-2021-069676Cai, Wu, Song, Metformin potentiates nephrotoxicity by promoting nEtosis in response to renal ferroptosis, Cell discov,
doi:10.1038/s41421-023-00595-3Cao T, Xu, Xu, the protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro, int urol nephrol,
doi:10.1007/s11255-019-02241-yCheng, Li, Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVid-19 and pre-existing type 2 diabetes, Cell Metab,
doi:10.1016/j.cmet.2020.08.013Eym, Palmer, Natale, incidence and outcomes of COVid-19 in people with CKd: a systematic review and meta-analysis, am J Kidney dis,
doi:10.1053/j.ajkd.2021.07.003Fadini, Ml, Exposure to dipeptidyl-peptidase-4 inhibitors and COVid-19 among people with type 2 diabetes: a case-control study, diabetes Obes Metab,
doi:10.1111/dom.14097Fernandez-Fernandez B, D'marco L, Jl, Exploring sodium glucose co-transporter-2 (SGlt2) inhibitors for organ protection in COVid-19, J Clin Med,
doi:10.3390/jcm9072030Hs, Sandhu, Sharma Ak, Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin, J. ]. 3 Biotech,
doi:10.1007/s13205-013-0121-9Huang, Ma, Pranata, diabetes mellitus is associated with increased mortality and severity of disease in COVid-19 pneumonia -a systematic review, meta-analysis, and meta-regression, diabetes Metab Syndr,
doi:10.1016/j.dsx.2020.04.018Huang, Yao, Chen, Metabolic syndrome and socioeconomic status in association with chronic kidney disease: a cross-sectional study in ningbo, China. diabetes, Metab Syndr Obes,
doi:10.2147/DMSO.S473299Ja, Memon, Rehan, the impact of COVid-19 in diabetic kidney disease and chronic kidney disease: a population-based study, acta Bio Medica: atenei Parmensis
Kahkoska Ar, Gc, association between glucagon-like peptide 1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use and COVid-19 outcomes, diabetes Care,
doi:10.2337/dc21-0065Kdoqi, Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease, am J Kidney dis
Koufakis T, Pavlidis An, Metallidis, Sodium-glucose co-transporter 2 inhibitors in COVid-19: meeting at the crossroads between heart, diabetes and infectious diseases, int J Clin Pharm,
doi:10.1007/s11096-021-01256-9Liang, association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies, Crit Care,
doi:10.1186/s13054-019-2346-4Lin, the association between antidiabetic agents and clinical outcomes of COVid-19 patients with diabetes: a Bayesian network meta-analysis, Front Endocrinol,
doi:10.3389/fendo.2022.895458Martini N, Piccinni, Pedrini, CoVid-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project, Recenti Prog Med,
doi:10.1701/3347.33180Oscanoa, Vidal, Metformin therapy and severity and mortality of SaRS-CoV-2 infection: a meta-analysis, Clin diabetol,
doi:10.5603/DK.a2021.0035Pérez-Belmonte Lm, Torres-Peña, Jd, Md, Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVid-19 in association with hypoglycemic drugs: a nationwide cohort study, BMC Med,
doi:10.1186/s12916-020-01832-2Schiller, Solger, diabetes-associated nephropathy and obesity influence COVid-19 outcome in type 2 diabetes patients, J Community Hosp intern Med Perspect,
doi:10.1080/20009666.2021.1957555Shen Y, Chen Y, Huang, the association between symptoms of depression and anxiety, quality of life, and diabetic kidney disease among chinese adults: a cross-sectional study, int J Environ Res Public Health,
doi:10.3390/ijerph20010475Singh, Verma, Gera N, Evaluation of Cordyceps militaris steroids as anti-inflammatory agents to combat the Covid-19 cytokine storm: a bioinformatics and structure-based drug designing approach, J Biomol Struct dyn,
doi:10.1080/07391102.2023.2245039Solerte, Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVid-19: a multicenter, case-control, retrospective, observational study, diabetes Care,
doi:10.2337/dc20-1521Verma Ak, Cordycepin: a bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVid-19, J Biomol Struct dyn,
doi:10.1080/07391102.2020.1850352Who, WHO Coronavirus (COVid-19) dashboard
Wong, use of dPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVid-19 patients with type 2 diabetes: propensity score analysis of a territory-wide cohort in Hong Kong, diabetes Metab,
doi:10.1016/j.diabet.2021.101307Xiao, Zhou Yc, Zhang, Hyperglycemia and blood glucose deterioration are risk factors for severe COVid-19 with diabetes: a two-center cohort study, J Med Virol,
doi:10.1002/jmv.27556Yang Y, Zou, Xu, an update on the interaction between COVid-19, vaccines, and diabetic kidney disease, Front immunol,
doi:10.3389/fimmu.2022.999534Zhang, Glucose-lowering drugs and outcome from COVid-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong, BMJ Open,
doi:10.1136/bmjopen-2021-052310Zheng, Zhang, Song, Cordycepin from Cordyceps militaris ameliorates diabetic nephropathy via the miR-193b-5p/MCl-1 axis, Chin Med,
doi:10.1186/s13020-023-00842-5DOI record:
{
"DOI": "10.1080/0886022x.2025.2584572",
"ISSN": [
"0886-022X",
"1525-6049"
],
"URL": "http://dx.doi.org/10.1080/0886022X.2025.2584572",
"alternative-id": [
"10.1080/0886022X.2025.2584572"
],
"article-number": "2584572",
"assertion": [
{
"label": "Peer Review Statement",
"name": "peerreview_statement",
"order": 1,
"value": "The publishing and review policy for this title is described in its Aims & Scope."
},
{
"URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=irnf20",
"label": "Aim & Scope",
"name": "aims_and_scope_url",
"order": 2,
"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=irnf20"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Received",
"name": "received",
"order": 0,
"value": "2025-01-05"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Revised",
"name": "revised",
"order": 1,
"value": "2025-10-26"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Accepted",
"name": "accepted",
"order": 2,
"value": "2025-10-27"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Published",
"name": "published",
"order": 3,
"value": "2025-11-17"
}
],
"author": [
{
"affiliation": [
{
"name": "School of Medicine, Ningbo University",
"place": [
"Ningbo, China"
]
}
],
"family": "Liu",
"given": "Yanan",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Department of Medicine, The First Affiliated Hospital, Ningbo University",
"place": [
"Ningbo, China"
]
}
],
"family": "Yao",
"given": "Xuejie",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "School of Medicine, Zhejiang University",
"place": [
"Hangzhou, China"
]
}
],
"family": "Xu",
"given": "Jianhang",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham",
"place": [
"Nottingham, United Kingdom"
]
},
{
"name": "China Health Institute, University of Nottingham Ningbo China",
"place": [
"Ningbo, China"
]
}
],
"family": "Hubbard",
"given": "Richard",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Rural Health Research Institute, Charles Sturt University",
"place": [
"Orange, Australia"
]
}
],
"family": "Ross",
"given": "Allen G.",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Rural Health Research Institute, Charles Sturt University",
"place": [
"Orange, Australia"
]
}
],
"family": "Shiddiky",
"given": "Muhammad J. A.",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Medicine, The First Affiliated Hospital, Ningbo University",
"place": [
"Ningbo, China"
]
},
{
"name": "China Health Institute, University of Nottingham Ningbo China",
"place": [
"Ningbo, China"
]
}
],
"family": "Zhan",
"given": "Ming",
"sequence": "additional"
}
],
"container-title": "Renal Failure",
"container-title-short": "Renal Failure",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"www.tandfonline.com"
]
},
"created": {
"date-parts": [
[
2025,
11,
18
]
],
"date-time": "2025-11-18T02:26:27Z",
"timestamp": 1763432787000
},
"deposited": {
"date-parts": [
[
2025,
11,
18
]
],
"date-time": "2025-11-18T02:26:35Z",
"timestamp": 1763432795000
},
"funder": [
{
"DOI": "10.13039/100007834",
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/100007834",
"id-type": "DOI"
}
],
"name": "Ningbo Natural Science Foundation"
},
{
"name": "Zhejiang Medical Technology Project"
}
],
"indexed": {
"date-parts": [
[
2025,
11,
18
]
],
"date-time": "2025-11-18T02:30:40Z",
"timestamp": 1763433040496,
"version": "3.45.0"
},
"is-referenced-by-count": 0,
"issue": "1",
"issued": {
"date-parts": [
[
2025,
11,
17
]
]
},
"journal-issue": {
"issue": "1",
"published-print": {
"date-parts": [
[
2025,
12,
31
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by-nc/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
11,
17
]
],
"date-time": "2025-11-17T00:00:00Z",
"timestamp": 1763337600000
}
}
],
"link": [
{
"URL": "https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2025.2584572",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "301",
"original-title": [],
"prefix": "10.1080",
"published": {
"date-parts": [
[
2025,
11,
17
]
]
},
"published-online": {
"date-parts": [
[
2025,
11,
17
]
]
},
"published-print": {
"date-parts": [
[
2025,
12,
31
]
]
},
"publisher": "Informa UK Limited",
"reference": [
{
"key": "e_1_3_6_2_1",
"unstructured": "WHO. WHO Coronavirus (COVID-19) dashboard. [updated 2024 Jun 30 cited 2024 Jul 01]. Available from: https://covid19.who.int/."
},
{
"DOI": "10.1701/3347.33180",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_3_1"
},
{
"DOI": "10.1053/j.ajkd.2014.08.001",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_4_1"
},
{
"DOI": "10.2174/0929867330666230621112215",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_5_1"
},
{
"DOI": "10.1080/20009666.2021.1957555",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_6_1"
},
{
"article-title": "The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: a population-based study",
"author": "Leon-Abarca JA",
"issue": "4",
"journal-title": "Acta Bio Medica: atenei Parmensis",
"key": "e_1_3_6_7_1",
"unstructured": "Leon-Abarca JA, Memon RS, Rehan B, et al. The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: a population-based study. Acta Bio Medica: atenei Parmensis. 2020;91(4):e2020161.",
"volume": "91",
"year": "2020"
},
{
"DOI": "10.3389/fimmu.2022.999534",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_8_1"
},
{
"DOI": "10.1016/j.artere.2021.04.004",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_9_1"
},
{
"DOI": "10.1097/MS9.0000000000002053",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_10_1"
},
{
"DOI": "10.1016/j.cmet.2014.09.018",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_11_1"
},
{
"DOI": "10.1161/CIRCRESAHA.116.308445",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_12_1"
},
{
"DOI": "10.1186/s13054-019-2346-4",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_13_1"
},
{
"DOI": "10.2337/dc20-1521",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_14_1"
},
{
"DOI": "10.1080/03007995.2022.2027141",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_15_1"
},
{
"DOI": "10.2337/dc21-0065",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_16_1"
},
{
"DOI": "10.1186/s13020-023-00842-5",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_17_1"
},
{
"DOI": "10.1007/s13205-013-0121-9",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_18_1"
},
{
"DOI": "10.1056/NEJMoa2035389",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_19_1"
},
{
"DOI": "10.1136/bmj-2021-069676",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_20_1"
},
{
"DOI": "10.3390/ijerph20010475",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_21_1"
},
{
"DOI": "10.2147/DMSO.S473299",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_22_1"
},
{
"article-title": "Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease",
"author": "Kdoqi KDOQI",
"first-page": "S62",
"issue": "2",
"journal-title": "Am J Kidney Dis",
"key": "e_1_3_6_23_1",
"unstructured": "Kdoqi KDOQI. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(Suppl. S2):S62–S73.",
"volume": "49",
"year": "2007"
},
{
"DOI": "10.1016/j.chmed.2022.11.008",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_24_1"
},
{
"DOI": "10.1136/bmjopen-2021-052310",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_25_1"
},
{
"DOI": "10.1002/jmv.27556",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_26_1"
},
{
"DOI": "10.1007/s11096-021-01256-9",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_27_1"
},
{
"DOI": "10.1111/eci.13339",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_28_1"
},
{
"DOI": "10.3389/fendo.2022.895458",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_29_1"
},
{
"DOI": "10.1016/j.kint.2020.03.005",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_30_1"
},
{
"DOI": "10.3390/jcm9072030",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_31_1"
},
{
"DOI": "10.1111/dom.14097",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_32_1"
},
{
"DOI": "10.1186/s12916-020-01832-2",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_33_1"
},
{
"DOI": "10.1016/j.diabet.2021.101307",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_34_1"
},
{
"DOI": "10.1111/apha.12644",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_35_1"
},
{
"DOI": "10.2337/dbi19-0023",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_36_1"
},
{
"DOI": "10.5603/DK.a2021.0035",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_37_1"
},
{
"DOI": "10.3389/fmed.2021.644295",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_38_1"
},
{
"DOI": "10.1038/s41421-023-00595-3",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_39_1"
},
{
"DOI": "10.1016/j.cmet.2020.08.013",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_40_1"
},
{
"DOI": "10.1007/s11255-019-02241-y",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_41_1"
},
{
"DOI": "10.1080/07391102.2020.1850352",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_42_1"
},
{
"DOI": "10.1080/07391102.2023.2245039",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_43_1"
},
{
"DOI": "10.1080/07391102.2023.2225110",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_44_1"
},
{
"DOI": "10.1016/j.dsx.2020.04.018",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_45_1"
},
{
"DOI": "10.1016/S2213-8587(20)30272-2",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_46_1"
},
{
"DOI": "10.1053/j.ajkd.2021.07.003",
"doi-asserted-by": "publisher",
"key": "e_1_3_6_47_1"
}
],
"reference-count": 46,
"references-count": 46,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.tandfonline.com/doi/full/10.1080/0886022X.2025.2584572"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Associations of hypoglycemic medications, cordycepin and vaccination with clinical outcomes in diabetic kidney disease patients with COVID-19",
"type": "journal-article",
"update-policy": "https://doi.org/10.1080/tandf_crossmark_01",
"volume": "47"
}
